|Graduate School||University of Iowa|
|Fellowship||University of California, San Diego|
|Special Interest||Deep learning applications in imaging and visual function in glaucoma|
Mark Christopher is an Assistant Project Scientist at the University of California, San Diego. Dr. Christopher received his undergraduate and graduate training from the Department of Biomedical Engineering at the University of Iowa.
Dr. Christopher’s research focuses on using computational tools to study ophthalmic disease. His active projects include applying machine and deep learning techniques to perform early disease detection, structure-function prediction, and longitudinal analysis of disease progression. Dr. Christopher currently holds an NIH K99 Pathway to Independence award.
The information contained in this online site is intended to provide accurate and helpful health information for the general public. It is made available with the understanding that the author and publisher are not engaged in rendering medical, health, psychological, or any other kind of personal professional services on this site. The information should not be considered complete and does not cover all diseases, ailments, physical conditions or their treatment. It should not be used in place of a call or visit to a medical, health or other competent professional, who should be consulted before adopting any of the suggestions in this site or drawing inferences from it.
The information about drugs contained on this site is general in nature. It does not cover all possible uses, actions, precautions, side effects, or interactions of the medicines mentioned, nor is the information intended as medical advice for individual problems or for making an evaluation as to the risks and benefits of taking a particular drug.
The operator(s) of this site, and the publisher, specifically disclaim all responsibility for any liability, loss or risk, personal or otherwise, which is incurred as a consequence, directly or indirectly, of the use and application of any of the material on this site.
Click Here To Accept